A carregar...
Mirabegron as adjuvant treatment for patients with interstitial cystitis/bladder pain syndrome
INTRODUCTION: Interstitial cystitis/bladder pain syndrome (IC/BPS) patients represent a heterogeneous group with pain and urinary storage symptoms and varying responses to current treatment options. The novel beta-3 agonist, mirabegron, has been shown to improve storage symptoms of patients with bla...
Na minha lista:
| Publicado no: | Can Urol Assoc J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Canadian Medical Association
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5869033/ https://ncbi.nlm.nih.gov/pubmed/29283084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4325 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|